Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Applied ABT-199 (Venetoclax) Workflows in Apoptosis Research
2026-06-25
ABT-199 (Venetoclax) redefines selectivity in apoptosis assays, enabling precise interrogation of Bcl-2-dependent pathways in hematologic malignancies. This article delivers advanced experimental workflows, troubleshooting strategies, and evidence-backed protocol enhancements for reliable, interpretable results in non-Hodgkin lymphoma and AML research.
-
Pseudo-UTP: Advancing mRNA Synthesis with Pseudouridine Modi
2026-06-25
Pseudo-UTP delivers superior RNA stability, translation efficiency, and reduced immunogenicity, powering next-generation mRNA synthesis for vaccine and gene therapy workflows. This guide details advanced use-cases, protocol upgrades, and troubleshooting strategies—driven by real-world studies and expert insights.
-
Hypoxia-Activated Photomolecular Glues: Synergistic Cyclin K
2026-06-24
This study introduces BNNC, a hypoxia-activated photomolecular glue designed to synergistically degrade Cyclin K and induce phototherapeutic DNA damage specifically in tumor microenvironments. The findings highlight enhanced tumor selectivity, increased apoptosis, and improved antitumor efficacy, with direct implications for the rational design of safer, more effective cancer treatments.
-
GI 254023X: Selective ADAM10 Inhibition in Neurovascular Mod
2026-06-23
Explore GI 254023X, a potent ADAM10 inhibitor, as a precision research tool for neurovascular biology. This article uniquely examines cross-talk between endothelial barrier integrity and neurodegenerative signaling, offering advanced assay insights.
-
Dorsomorphin (Compound C): Reliable Inhibition for Cell Assa
2026-06-23
This evidence-based guide addresses real laboratory challenges when using Dorsomorphin (Compound C), SKU B3252, for AMPK and BMP pathway studies. Through practical scenarios, it demonstrates how this reagent from APExBIO delivers consistent performance, protocol adaptability, and data-backed reliability for cell viability, proliferation, and cytotoxicity assays.
-
Brassinolide (A3265): Mechanisms, Evidence, and Research Par
2026-06-22
Brassinolide is a powerful plant growth regulator and apoptosis inducer. It modulates plant morphogenesis and has validated activity in cancer and diabetes models. This article details its mechanisms, benchmarks, and research protocols for reliable application.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Practical Guide
2026-06-22
The Annexin V-FITC/PI Apoptosis Assay Kit enables researchers to rapidly and reliably distinguish between viable, early apoptotic, and late apoptotic or necrotic cells by leveraging differential membrane integrity and phosphatidylserine externalization. This kit is best suited for laboratory research workflows requiring reproducible, stage-specific apoptosis detection using flow cytometry or fluorescence microscopy. It is not intended for diagnostic or medical applications.
-
Ceftazidime: Third-Generation Cephalosporin in Infection Res
2026-06-21
Ceftazidime stands out as a third-generation cephalosporin, excelling in the study and management of Gram-negative bacterial infections, especially those caused by Pseudomonas aeruginosa and multidrug-resistant Enterobacteriaceae. This article bridges the latest epidemiologic findings with practical, workflow-driven insights for maximizing ceftazidime’s impact in both experimental and translational settings.
-
WDR36 Controls Trophectoderm Fate via Glycolytic Regulation
2026-06-20
This study reveals that WDR36 is a critical regulator of trophectoderm lineage commitment during human preimplantation development, acting through modulation of glycolytic metabolism. The mechanistic insights, established using human blastoid models, suggest new directions for understanding early embryonic arrest and potential therapeutic targets.
-
CHIR-99021 (CT99021): Benchmarking a Selective GSK-3 Inhibit
2026-06-19
CHIR-99021 (CT99021) is a potent, selective GSK-3 inhibitor widely used to modulate Wnt/β-catenin signaling and maintain embryonic stem cell pluripotency. Its high selectivity and nanomolar potency enable reproducible differentiation protocols and advanced disease modeling. This article details its mechanism, evidence base, and practical workflow integration.
-
Obeticholic Acid in Liver Fibrosis Research: Applied FXR Ago
2026-06-19
Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid) enables precise modulation of bile acid homeostasis and advanced modeling of hepatic fibrosis. This article delivers stepwise protocols, troubleshooting tips, and actionable insights that leverage APExBIO's high-purity compound for translational liver disease studies.
-
Perospirone’s Inhibition of Kv1.5 Channels in Coronary VSMCs
2026-06-18
A recent study demonstrates that Perospirone (SM-9018 free base), a second-generation antipsychotic, potently inhibits vascular Kv1.5 channels in rabbit coronary arterial smooth muscle cells. This off-target action, independent of classic serotonergic and dopaminergic pathways, reveals unrecognized cardiovascular implications with significance for both neuropsychiatric and vascular research models.
-
RapaLink-1: Third-Generation mTOR Inhibitor for Dormancy & C
2026-06-18
RapaLink-1 is a third-generation mTOR inhibitor that achieves potent, bivalent inhibition of mTORC1, overcoming resistance mutations and enabling both tumor regression and reliable induction of reversible embryonic dormancy. It demonstrates superior efficacy compared to prior mTOR inhibitors in cancer and developmental biology models.
-
Annexin V-FITC/PI Apoptosis Assay Kit: Precision in Apoptosi
2026-06-17
Discover how the Annexin V-FITC/PI Apoptosis Assay Kit enables nuanced, quantitative analysis of apoptosis stages in cancer and beyond. Explore its unique mechanistic strengths, protocol guidance, and translational insights for research advancement.
-
EdU Imaging Kits (488): Advanced Cell Proliferation Assays
2026-06-17
EdU Imaging Kits (488) streamline S-phase DNA synthesis detection with click chemistry, delivering superior sensitivity and cell preservation over BrdU assays. This guide details optimized experimental workflows, troubleshooting strategies, and real-world applications—empowering advanced cell proliferation research in oncology and regenerative medicine.